Marina Romero-Ramos, Ph.D. - Publications

Medical Biochemistry Aarhus University, Aarhus, Denmark 
Parkinson's disease

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Juul-Madsen K, Qvist P, Bendtsen KL, Langkilde AE, Vestergaard B, Howard KA, Dehesa-Etxebeste M, Paludan SR, Andersen GR, Jensen PH, Otzen DE, Romero-Ramos M, Vorup-Jensen T. Size-Selective Phagocytic Clearance of Fibrillar α-Synuclein through Conformational Activation of Complement Receptor 4. Journal of Immunology (Baltimore, Md. : 1950). PMID 31969389 DOI: 10.4049/Jimmunol.1900494  0.56
2019 Nissen SK, Shrivastava K, Schulte C, Otzen DE, Goldeck D, Berg D, Møller HJ, Maetzler W, Romero-Ramos M. Alterations in Blood Monocyte Functions in Parkinson's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31449711 DOI: 10.1002/mds.27815  0.56
2018 Olesen MN, Christiansen JR, Petersen SV, Jensen PH, Paslawski W, Romero-Ramos M, Sanchez-Guajardo V. CD4 T cells react to local increase of α-synuclein in a pathology-associated variant-dependent manner and modify brain microglia in absence of brain pathology. Heliyon. 4: e00513. PMID 29560431 DOI: 10.1016/J.Heliyon.2018.E00513  0.56
2016 Tentillier N, Etzerodt A, Olesen MN, Rizalar FS, Jacobsen J, Bender D, Moestrup SK, Romero-Ramos M. Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 9375-90. PMID 27605613 DOI: 10.1523/Jneurosci.1636-16.2016  0.56
2016 Christiansen JR, Olesen MN, Otzen DE, Romero-Ramos M, Sanchez-Guajardo V. α-Synuclein vaccination modulates regulatory T cell activation and microglia in the absence of brain pathology. Journal of Neuroinflammation. 13: 74. PMID 27055651 DOI: 10.1186/S12974-016-0532-8  0.92
2015 Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments. Neuroscience. PMID 25684748 DOI: 10.1016/J.Neuroscience.2015.02.008  0.92
2014 Delenclos M, Carrascal L, Jensen K, Romero-Ramos M. Immunolocalization of human alpha-synuclein in the Thy1-aSyn ("Line 61") transgenic mouse line. Neuroscience. 277: 647-64. PMID 25090921 DOI: 10.1016/J.Neuroscience.2014.07.042  0.92
2014 Romero-Ramos M, von Euler Chelpin M, Sanchez-Guajardo V. Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance? Human Vaccines & Immunotherapeutics. 10: 852-67. PMID 24670306 DOI: 10.4161/Hv.28578  0.92
2013 Sanchez-Guajardo V, Annibali A, Jensen PH, Romero-Ramos M. α-Synuclein vaccination prevents the accumulation of parkinson disease-like pathologic inclusions in striatum in association with regulatory T cell recruitment in a rat model. Journal of Neuropathology and Experimental Neurology. 72: 624-45. PMID 23771222 DOI: 10.1097/Nen.0B013E31829768D2  0.92
2013 Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D, Romero-Ramos M. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease. Neurobiology of Disease. 56: 47-58. PMID 23567651 DOI: 10.1016/J.Nbd.2013.03.014  0.92
2013 Febbraro F, Andersen KJ, Sanchez-Guajardo V, Tentillier N, Romero-Ramos M. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Experimental Neurology. 247: 45-58. PMID 23531432 DOI: 10.1016/J.Expneurol.2013.03.017  0.92
2013 Sanchez-Guajardo V, Barnum CJ, Tansey MG, Romero-Ramos M. Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. Asn Neuro. 5: 113-39. PMID 23506036 DOI: 10.1042/An20120066  0.92
2013 Febbraro F, Sahin G, Farran A, Soares S, Jensen PH, Kirik D, Romero-Ramos M. Corrigendum to "Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease" [Neurobiol. Dis. 56 (2013) 48-58] Neurobiology of Disease. 58: 191. DOI: 10.1016/J.Nbd.2013.06.003  0.92
2012 Febbraro F, Giorgi M, Caldarola S, Loreni F, Romero-Ramos M. α-Synuclein expression is modulated at the translational level by iron. Neuroreport. 23: 576-80. PMID 22581044 DOI: 10.1097/Wnr.0B013E328354A1F0  0.92
2012 Barkholt P, Sanchez-Guajardo V, Kirik D, Romero-Ramos M. Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates. Neuroscience. 208: 85-96. PMID 22342967 DOI: 10.1016/J.Neuroscience.2012.02.004  0.92
2011 Decressac M, Ulusoy A, Mattsson B, Georgievska B, Romero-Ramos M, Kirik D, Björklund A. GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease. Brain : a Journal of Neurology. 134: 2302-11. PMID 21712347 DOI: 10.1093/Brain/Awr149  0.92
2011 Bøttger P, Tracz Z, Heuck A, Nissen P, Romero-Ramos M, Lykke-Hartmann K. Distribution of Na/K-ATPase alpha 3 isoform, a sodium-potassium P-type pump associated with rapid-onset of dystonia parkinsonism (RDP) in the adult mouse brain. The Journal of Comparative Neurology. 519: 376-404. PMID 21165980 DOI: 10.1002/Cne.22524  0.92
2010 Ulusoy A, Febbraro F, Jensen PH, Kirik D, Romero-Ramos M. Co-expression of C-terminal truncated alpha-synuclein enhances full-length alpha-synuclein-induced pathology. The European Journal of Neuroscience. 32: 409-22. PMID 20704592 DOI: 10.1111/J.1460-9568.2010.07284.X  0.92
2010 Sanchez-Guajardo V, Febbraro F, Kirik D, Romero-Ramos M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson's disease. Plos One. 5: e8784. PMID 20098715 DOI: 10.1371/Journal.Pone.0008784  0.92
2009 Wilms H, Rosenstiel P, Romero-Ramos M, Arlt A, Schäfer H, Seegert D, Kahle PJ, Odoy S, Claasen JH, Holzknecht C, Brandenburg LO, Deuschl G, Schreiber S, Kirik D, Lucius R. Suppression of MAP kinases inhibits microglial activation and attenuates neuronal cell death induced by alpha-synuclein protofibrils. International Journal of Immunopathology and Pharmacology. 22: 897-909. PMID 20074453  0.92
2007 Eslamboli A, Romero-Ramos M, Burger C, Bjorklund T, Muzyczka N, Mandel RJ, Baker H, Ridley RM, Kirik D. Long-term consequences of human alpha-synuclein overexpression in the primate ventral midbrain. Brain : a Journal of Neurology. 130: 799-815. PMID 17303591 DOI: 10.1093/Brain/Awl382  0.92
2006 Maingay M, Romero-Ramos M, Carta M, Kirik D. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression. Neurobiology of Disease. 23: 522-32. PMID 16806952 DOI: 10.1016/J.Nbd.2006.04.007  0.92
2005 Kirik D, Björklund A. Parkinson's disease: viral vector delivery of parkin generates model results in rats. Gene Therapy. 12: 727-9. PMID 19202633 DOI: 10.1038/Sj.Gt.3302497  0.92
2005 Mignon L, Vourc'h P, Romero-Ramos M, Osztermann P, Young HE, Lucas PA, Chesselet MF. Transplantation of multipotent cells extracted from adult skeletal muscles into the subventricular zone of adult rats. The Journal of Comparative Neurology. 491: 96-108. PMID 16127692 DOI: 10.1002/Cne.20685  0.92
2005 Maingay M, Romero-Ramos M, Kirik D. Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease. Cns Spectrums. 10: 235-44. PMID 15744224 DOI: 10.1017/S1092852900010075  0.92
2004 Vourc'h P, Romero-Ramos M, Chivatakarn O, Young HE, Lucas PA, El-Kalay M, Chesselet MF. Isolation and characterization of cells with neurogenic potential from adult skeletal muscle. Biochemical and Biophysical Research Communications. 317: 893-901. PMID 15081424 DOI: 10.1016/J.Bbrc.2004.03.121  0.92
2004 Young HE, Duplaa C, Romero-Ramos M, Chesselet MF, Vourc'h P, Yost MJ, Ericson K, Terracio L, Asahara T, Masuda H, Tamura-Ninomiya S, Detmer K, Bray RA, Steele TA, Hixson D, et al. Adult reserve stem cells and their potential for tissue engineering. Cell Biochemistry and Biophysics. 40: 1-80. PMID 14983110 DOI: 10.1385/Cbb:40:1:1  0.92
2003 Romero-Ramos M, Venero JL, Garcia-Rodriguez S, Ayala A, Machado A, Cano J. Semichronic inhibition of glutathione reductase promotes oxidative damage to proteins and induces both transcription and translation of tyrosine hydroxylase in the nigrostriatal system. Free Radical Research. 37: 1003-12. PMID 14670008 DOI: 10.1080/10715760310001598574  0.92
2002 Romero-Ramos M, Vourc'h P, Young HE, Lucas PA, Wu Y, Chivatakarn O, Zaman R, Dunkelman N, el-Kalay MA, Chesselet MF. Neuronal differentiation of stem cells isolated from adult muscle. Journal of Neuroscience Research. 69: 894-907. PMID 12205682 DOI: 10.1002/Jnr.10374  0.92
2000 Romero-Ramos M, Venero JL, Cano J, Machado A. Low selenium diet induces tyrosine hydroxylase enzyme in nigrostriatal system of the rat. Brain Research. Molecular Brain Research. 84: 7-16. PMID 11113527 DOI: 10.1016/S0169-328X(00)00171-6  0.92
2000 Romero-Ramos M, Venero JL, Santiago M, Rodriguez-Gómez JA, Vizuete ML, Cano J, Machado A. Decreased messenger RNA expression of key markers of the nigrostriatal dopaminergic system following vitamin E deficiency in the rat. Neuroscience. 101: 1029-36. PMID 11113352 DOI: 10.1016/S0306-4522(00)00424-3  0.92
1997 Rodríguez-Gómez JA, Romero-Ramos M, Vizuete ML, Venero JL, Cano J, Machado A. Increased activity and expression of tyrosine hydroxylase in the rat substantia nigra after chronic treatment with nomifensine. Molecular Pharmacology. 52: 641-7. PMID 9380027 DOI: 10.1124/Mol.52.4.641  0.92
1997 Romero-Ramos M, Rodríguez-Gómez JA, Venero JL, Cano J, Machado A. Chronic inhibition of the high-affinity dopamine uptake system increases oxidative damage to proteins in the aged rat substantia nigra. Free Radical Biology & Medicine. 23: 1-7. PMID 9165291 DOI: 10.1016/S0891-5849(96)00405-4  0.92
1997 Revuelta M, Romero-Ramos M, Venero JL, Millan F, Machado A, Cano J. Less induced 1-methyl-4-phenylpyridinium ion neurotoxicity on striatal slices from guinea-pigs fed with a vitamin C-deficient diet. Neuroscience. 77: 167-74. PMID 9044384 DOI: 10.1016/S0306-4522(96)00491-5  0.92
1995 Venero JL, Romero-Ramos M, Revuelta M, Machado A, Cano J. Intrastriatal quinolinic acid injections protect against 6-hydroxydopamine-induced lesions of the dopaminergic nigrostriatal system. Brain Research. 672: 153-8. PMID 7749737 DOI: 10.1016/0006-8993(94)01368-R  0.92
Show low-probability matches.